Connected tools, unified data, complete confidence
Chronic respiratory conditions and sleep-related breathing disorders are among the most underdiagnosed and undertreated health concerns worldwide. Despite growing awareness, an estimated 80% of moderate to severe cases of obstructive sleep apnea (OSA) remain undiagnosed,1 while studies suggest that up to 70% of chronic obstructive pulmonary disease (COPD) go undetected globally.2
Beyond underdiagnosis, respiratory care is often managed across fragmented systems and workflows, making it difficult to coordinate data, streamline communication, and maintain continuity across the patient journey. These gaps highlight a critical need for tools that connect each step of the patient journey—from initial screening to diagnosis, treatment setup, and long-term management.
The Nonin Health® platform and WristOx2® Model 3150BLE pulse oximeter provide that connection. Together, they deliver a single solution that simplifies data capture, streamlines communication, and supports faster, more informed decisions across the continuum of patient care.
Connecting care through a single platform
In many respiratory care pathways, data collection happens in silos. Separate systems and workflows handle pre-screenings, diagnostics, and therapy follow-up, leading to inefficiencies and lost insights. The Nonin Health platform bridges these gaps with secure, cloud-based access to pulse oximetry data that is accurate,4 actionable, and easy to share across teams.
By pairing seamlessly with the WristOx2, the Nonin Health platform enables healthcare professionals to collect, transmit, and review oxygen saturation (SpO2) and pulse rate data through an intuitive mobile app and online portal. The result is a unified workflow that eliminates manual transfers, reduces turnaround time, and supports coordinated, patient-centered care.3
Stage 1: Early detection and pre-screening
Effective respiratory care begins with early detection. The WristOx2 is an optimal tool for pre-screening patients who may be at risk for sleep-related breathing disorders or chronic respiratory disease. When paired with the Nonin Health mobile app, clinicians can easily collect overnight oximetry data from a patient’s home environment and review results before the device is shipped back.
Secure, cloud-based data transmission allows providers to review results promptly and determine next steps without delay. This efficiency not only accelerates diagnosis but also reduces administrative burden, helping clinicians serve more patients with fewer logistical obstacles.3
Stage 2: Diagnosis and therapy qualification
Once a patient’s risk is identified, the Nonin Health platform supports key diagnostic workflows, including oxygen qualification, using the same WristOx2 device. Compatibility also extends to other software platforms and applications. When paired with the WristOx2, platforms such as EnsoData can support HST for OSA diagnostic studies.
Because the Nonin Health platform automatically syncs oximetry data to a secure, HIPAA-compliant cloud portal, clinicians gain timely access to accurate4 readings without delays of manual uploads or physical data transfer. Faster access to data means patients can begin treatment sooner, a key advantage when early intervention in COPD management can reduce exacerbation-related hospitalizations by up to 40%.5
Automated data transfer also reduces the risk of transcription errors or lost reports associated with manual uploads, ensuring a higher degree of data integrity and consistency across care settings.6
Stage 3: Therapy monitoring and adjustment
After diagnosis, ongoing therapy management becomes essential. Whether a patient is prescribed positive airway pressure (PAP) therapy, supplemental oxygen, or an oral appliance, the Nonin Health platform provides the data continuity needed to track progress and monitor the patient’s therapy.
The platform helps clinicians track therapy compliance and evaluate treatment effectiveness over time. For oral appliance titration, objective follow-up data can help clinicians assess treatment effectiveness and guide adjustments.7 The result: improved visibility helps clinicians monitor patients and their CPAP usage and adherence.
Stage 4: Re-care and long-term monitoring
Chronic respiratory management requires continuous evaluation to ensure sustained success. With the Nonin Health platform, clinicians can easily conduct re-care testing and periodic follow-ups using the same familiar WristOx2 device. This continuity simplifies the process for both providers and patients while maintaining consistency in data collection.
By centralizing oximetry data within one secure platform, Nonin Health supports longitudinal testing that helps strengthen clinical insight. Providers can track progress over time, identify changes early, and adjust therapy as needed—all within an efficient, digital workflow.
A more connected approach to care
The Nonin Health platform unifies data and devices to help clinicians manage respiratory and sleep-related conditions with confidence. Across the continuum of care—from first screening to long-term therapy management—the combination of the Nonin Health platform and the WristOx2 Model 3150BLE helps empower healthcare professionals to act quickly, communicate effectively, and make data-driven decisions to support patient care.